Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: Role for lysine residues in antimicrobial properties

被引:50
作者
Beck, Wendy H. J. [1 ]
Adams, Christopher P. [1 ]
Biglang-awa, Ivan M. [1 ]
Patel, Arti B. [1 ]
Vincent, Heather [2 ]
Haas-Stapleton, Eric J. [2 ]
Weers, Paul M. M. [1 ]
机构
[1] Calif State Univ Long Beach, Dept Chem & Biochem, Long Beach, CA 90840 USA
[2] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2013年 / 1828卷 / 06期
基金
美国国家卫生研究院;
关键词
Apolipoprotein apoA-I; Lipopolysaccharides; Phosphatidylglycerol; Antimicrobial; HIGH-DENSITY-LIPOPROTEIN; LIPID-FREE STRUCTURE; ESCHERICHIA-COLI; DOMAIN-STRUCTURE; ENDOTOXIN; VITRO; NEUTRALIZATION; FUNCTIONALITY; MECHANISMS; PEPTIDES;
D O I
10.1016/j.bbamem.2013.02.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Human apolipoprotein A-I (apoA-I) is a 28 kDa protein and a major component of high-density lipoproteins, mediating several essential metabolic functions related to heart disease. In the present study the potential protective role against bacterial pathogens was explored. ApoA-I suppressed bacterial growth of Escherichia coli and Klebsiella pneumoniae. The protein was able to bind lipopolysaccharides and showed a strong preference for bilayer vesicles made of phosphatidylglycerol over phosphatidylcholine. Lysine side chains of apoA-I were acetylated to evaluate the importance of electrostatic forces in the binding interaction with both membrane components. Electrophoresis properties, dot blot analysis, circular dichroism, and fluorescence spectroscopy to probe for changes in protein structure indicated that the acetylated protein displayed a strongly reduced lipopolysaccharide and phosphatidylglycerol binding. A mutant containing only the N-terminal domain of apoA-I also showed a reduced ability to interact with the membrane components, although to a lesser extent. These results indicate the potential for apoA-I to function as an antimicrobial protein and exerts this function through lysine residues. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1503 / 1510
页数:8
相关论文
共 43 条
[1]
[Anonymous], 1966, Methods Enzymol, DOI DOI 10.1016/0076-6879(66)08014-5
[2]
Apolipoprotein A-I Exerts Bactericidal Activity against Yersinia enterocolitica Serotype O:3 [J].
Biedzka-Sarek, Marta ;
Metso, Jari ;
Kateifides, Andreas ;
Meri, Taru ;
Jokiranta, T. Sakari ;
Muszynski, Artur ;
Radziejewska-Lebrecht, Joanna ;
Zannis, Vassilis ;
Skurnik, Mikael ;
Jauhiainen, Matti .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (44) :38211-38219
[3]
Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins [J].
Brandenburg, K ;
Jürgens, G ;
Andrä, J ;
Lindner, B ;
Koch, MHJ ;
Blume, A ;
Garidel, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (23) :5972-5981
[4]
Structural models of human apolipoprotein A-I: a critical analysis and review [J].
Brouillette, CG ;
Anantharamaiah, GM ;
Engler, JA ;
Borhani, DW .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2001, 1531 (1-2) :4-46
[5]
Apolipoprotein A-I lysine modification: Effects on helical content, lipid binding and cholesterol acceptor activity [J].
Brubaker, G ;
Peng, DQ ;
Somerlot, B ;
Abdollahian, DJ ;
Smith, JD .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (01) :64-72
[6]
The role of apolipoprotein AI domains in lipid binding [J].
Davidson, WS ;
Hazlett, T ;
Mantulin, WW ;
Jonas, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13605-13610
[7]
INVITRO INACTIVATION OF BACTERIAL-ENDOTOXIN BY HUMAN LIPOPROTEINS AND APOLIPOPROTEINS [J].
EMANCIPATOR, K ;
CSAKO, G ;
ELIN, RJ .
INFECTION AND IMMUNITY, 1992, 60 (02) :596-601
[8]
High density lipoprotein: it's not just about lipid transport anymore [J].
Gordon, Scott M. ;
Hofmann, Susanna ;
Askew, David S. ;
Davidson, W. Sean .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2011, 22 (01) :9-15
[9]
Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect [J].
Henning, Maria F. ;
Herlax, Vanesa ;
Bakas, Laura .
INNATE IMMUNITY, 2011, 17 (03) :327-337
[10]
HUBSCH AP, 1995, J LAB CLIN MED, V126, P548